H.R. 1, One Big Beautiful Bill Act, issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.
Literal federal measure citations: H.R. 1
2025 · 2nd Quarter (Apr 1 - June 30)
Filed by WILLIAMS AND JENSEN, PLLC.
Open official filingSource-reported fields
Literal source text
H.R. 1, One Big Beautiful Bill Act, issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.
Literal federal measure citations: H.R. 1
H.R. 1, One Big Beautiful Bill Act, issues related to R&D tax credit. Monitor trade and tariff issues related to pharmaceutical tariffs.
Literal federal measure citations: H.R. 1
H.R. 1, One Big Beautiful Bill Act, issues related to biopharmaceutical issues Prescription drug priing issues, particularly related to MFN.
Literal federal measure citations: H.R. 1
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.